Innoviva, Inc.
INVA
$17.21
-$0.08-0.46%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 48.85% | 136.86% | 93.07% | -2.20% | 34.88% |
| Total Other Revenue | -5.51% | 6.53% | 2.37% | 2.74% | 29.19% |
| Total Revenue | 6.95% | 33.08% | 23.34% | 1.48% | 30.45% |
| Cost of Revenue | -50.45% | -2.25% | -53.97% | -35.26% | 196.53% |
| Gross Profit | 52.56% | 39.48% | 55.84% | 17.25% | -9.73% |
| SG&A Expenses | 19.02% | -8.44% | 17.83% | 54.07% | 116.55% |
| Depreciation & Amortization | 0.02% | 0.00% | 29.89% | 69.25% | 59.95% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.41% | -6.18% | -13.83% | 11.22% | 38.87% |
| Operating Income | -1.43% | 141.00% | 91.72% | -13.68% | 23.80% |
| Income Before Tax | -59.65% | -92.03% | -776.64% | 9.68% | 194.61% |
| Income Tax Expenses | 1,421.82% | 44.29% | -201.52% | 36.92% | -109.10% |
| Earnings from Continuing Operations | -66.96% | -98.52% | -2,809.77% | 4.78% | 190.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -66.96% | -98.52% | -2,809.77% | 4.78% | 190.07% |
| EBIT | -1.43% | 141.00% | 91.72% | -13.68% | 23.80% |
| EBITDA | -1.25% | 103.33% | 82.52% | -4.22% | 27.38% |
| EPS Basic | -66.38% | -98.46% | -2,930.10% | 12.42% | 198.48% |
| Normalized Basic EPS | 7.19% | 162.64% | 108.10% | -9.75% | 43.34% |
| EPS Diluted | -63.01% | -98.03% | -2,930.10% | 10.39% | 177.63% |
| Normalized Diluted EPS | 6.35% | 246.14% | 108.61% | -10.66% | 7.46% |
| Average Basic Shares Outstanding | -1.70% | -3.67% | -4.31% | -6.79% | -8.54% |
| Average Diluted Shares Outstanding | -0.94% | -26.94% | -4.52% | -5.85% | 22.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
